Associated Papers
Novo pathogenic variations of NLRP7 increasing the risk of gestational trophoblastic neoplasia.
Tao C et al.
Clinical Genetics, 2023
Biallelic NLRP7 variants in patients with recurrent hydatidiform mole: A review and expert consensus.
Slim R et al.
Human Mutation, 2022
NLRP7: From inflammasome regulation to human disease.
Carriere J et al.
Immunology, 2021
NLRP7 and KHDC3L variants in Chinese patients with recurrent hydatidiform moles.
Ji M et al.
Japanese Journal of Clinical Oncology, 2019
Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization.
Sills ES et al.
Clinical and Experimental Reproductive Medicine, 2017
Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations.
Sebire NJ et al.
Placenta, 2013
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region.
Wang CM et al.
Journal of Medical Genetics, 2009
Select a paper to view details